JD Supra1d
Teva v. Amneal Oral Arguments and Claim Construction Order: Recent Developments in the Ongoing Debate Over the Orange Book Listing of Device Patents
As the FTC continues to crack down on pharmaceutical manufacturers’ allegedly improper listing of patents in the FDA Orange ...
TipRanks on MSN5d
Faron Pharmaceuticals Expands Pipeline with New Patent
Faron Pharmaceuticals Oy (GB:FARN) has released an update. Faron Pharmaceuticals has filed a patent application for the use ...
Managingip.com3d
Weighing ‘reasonable expectation of success’ in drug patent inventiveness assessments in China
Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical ...
3 Ways The New Administration Could Speed The Path To New Medicines
U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
With additional patents in the United States, Australia and Canada extending exclusivity until 2035, Lipella Pharmaceuticals is committed to providing value as it advances its clinical pipeline and ...
FiercePharma3d
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Bar & Bench1d
Delhi High Court restores order restraining Zydus from selling cancer drug after patent infringement claim
The Delhi High Court recently restored a single-judge order restraining Indian Pharma company Zydus Lifesciences ...
Merck: Keytruda's Sales Projections Outweigh Competitive And Patent Risks
Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...
Daily17h
Natco Pharma appoints Madhava Rao Karicherla as Associate Vice President - Formulation RnD, Pharma Division, Kothur Unit
Telangana: Natco Pharma has announced that Madhava Rao Karicherla has been appointed as Associate Vice President - ...
The post-election anti-abortion plan
Anti-abortion groups plan to unveil a sprawling federal and state strategy today that would undermine the procedure’s protections enacted by ballot measure in nearly a dozen states over the past two ...
Tharimmune granted patent for delivery of molecularly targeted therapeutics
Tharimmune (THAR) announced that the European Patent Office intends to grant the Company a patent covering biodegradable polymeric ...
IPWatchdog3d
Pharma Companies Fight it Out at High Court Over Whether CAFC Disregards Appellate Review Limits
A brief filed with the U.S. Supreme Court yesterday urged the Justices to deny a petition to the Court contending the U.S.